Cargando…

Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer's Disease

BACKGROUND: Alzheimer's disease (AD) is a major public health concern, and there is an urgent need to better understand its complex biology and develop effective therapies. AD progression can be tracked in patients through validated imaging and spinal fluid biomarkers of pathology and neuronal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petrella, Jeffrey R., Hao, Wenrui, Rao, Adithi, Doraiswamy, P. Murali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378032/ https://www.ncbi.nlm.nih.gov/pubmed/30863455 http://dx.doi.org/10.1155/2019/6216530

Ejemplares similares

Data-driven causal model discovery and personalized prediction in Alzheimer's disease
por: Zheng, Haoyang, et al.
Publicado: (2022)

Science to Practice: Translating Automated Brain MRI Volumetry in Alzheimer’s Disease from Research to Routine Diagnostic Use in the Work-Up of Dementia
por: Rathakrishnan, Bharath Gopal, et al.
Publicado: (2014)

Toward Personalized Network Biomarkers in Alzheimer's Disease: Computing Individualized Genomic and Protein Crosstalk Maps
por: Padmanabhan, Kanchana, et al.
Publicado: (2017)

Optimal anti-amyloid-beta therapy for Alzheimer’s disease via a personalized mathematical model
por: Hao, Wenrui, et al.
Publicado: (2022)

Dissecting the Gene Dose-Effects of the APOE ε4 and ε2 Alleles on Hippocampal Volumes in Aging and Alzheimer’s Disease
por: Hostage, Christopher A., et al.
Publicado: (2013)

Prevalence of Alzheimer’s Pathologic Endophenotypes in Asymptomatic and Mildly Impaired First-Degree Relatives
por: Lampert, Erika J., et al.
Publicado: (2013)

IMPACT OF CALORIE RESTRICTION ON PLASMA ALZHEIMER’S DISEASE BIOMARKERS IN HEALTHY YOUNG AND MIDDLE-AGED ADULTS
por: Parker, Daniel, et al.
Publicado: (2022)

Mobile and pervasive computing technologies and the future of Alzheimer’s clinical trials
por: Doraiswamy, P. Murali, et al.
Publicado: (2018)

Brain atrophy rates in first degree relatives at risk for Alzheimer's
por: Lampert, Erika J., et al.
Publicado: (2014)

Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer’s disease
por: Sohn, Dongwha, et al.
Publicado: (2018)

Impact of Computerized Cognitive Training on Default Mode Network Connectivity in Subjects at Risk for Alzheimer’s Disease: A 78-week Randomized Controlled Trial
por: Petrella, Jeffrey R., et al.
Publicado: (2023)

Sex‐specific biomarkers in Alzheimer's disease progression: Framingham Heart Study
por: Liu, Chunyu, et al.
Publicado: (2022)

When Mars Versus Venus is Not a Cliché: Gender Differences in the Neurobiology of Alzheimer’s Disease
por: Lin, Katherine Amy, et al.
Publicado: (2015)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
por: James, Olga G., et al.
Publicado: (2015)

Dynamic Causal Modeling of Preclinical Autosomal-Dominant Alzheimer’s Disease
por: Penny, Will, et al.
Publicado: (2018)

Underrepresentation of African-Americans in Alzheimer's Trials: A Call for Affirmative Action
por: Shin, Jaewook, et al.
Publicado: (2016)

Mathematical model on Alzheimer’s disease
por: Hao, Wenrui, et al.
Publicado: (2016)

Prognostic Value of Posteromedial Cortex Deactivation in Mild Cognitive Impairment
por: Petrella, Jeffrey R., et al.
Publicado: (2007)

Complex biomarker discovery in neuroimaging data: Finding a needle in a haystack()
por: Atluri, Gowtham, et al.
Publicado: (2013)

Identification of clusters of rapid and slow decliners among subjects at risk for Alzheimer’s disease
por: Gamberger, Dragan, et al.
Publicado: (2017)

Probing gut‐brain links in Alzheimer's disease with rifaximin
por: Suhocki, Paul V., et al.
Publicado: (2022)

Alzheimer’s Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint
por: Alawode, Deborah O. T., et al.
Publicado: (2022)

Advancing Computerized Cognitive Training for MCI and Alzheimer's Disease in a Pandemic and Post-pandemic World
por: Bodner, Kaylee A., et al.
Publicado: (2020)

Expanding the scope of health disparities research in Alzheimer's disease and related dementias: Recommendations from the “Leveraging Existing Data and Analytic Methods for Health Disparities Research Related to Aging and Alzheimer's Disease and Related Dementias” Workshop Series
por: Akushevich, Igor, et al.
Publicado: (2023)

Estimating effective connectivity in Alzheimer's disease progression: A dynamic causal modeling study
por: Huang, Jiali, et al.
Publicado: (2022)

The Causal Cascade to Multiple Sclerosis: A Model for MS Pathogenesis
por: Goodin, Douglas S.
Publicado: (2009)

Determining causal miRNAs and their signaling cascade in diseases using an influence diffusion model
por: Nalluri, Joseph J., et al.
Publicado: (2017)

Digital Therapeutics for MCI and Alzheimer’s disease: A Regulatory Perspective — Highlights From The Clinical Trials on Alzheimer’s Disease conference (CTAD)
por: Shuren, J., et al.
Publicado: (2022)

Mitochondria and Mitochondrial Cascades in Alzheimer’s Disease
por: Swerdlow, Russell H.
Publicado: (2018)

Cascading network failure across the Alzheimer’s disease spectrum
por: Jones, David T., et al.
Publicado: (2016)

Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease
por: Hassan, Mubashir, et al.
Publicado: (2018)

Marked gender differences in progression of mild cognitive impairment over 8 years
por: Lin, Katherine A., et al.
Publicado: (2015)

Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer’s disease from normal cognitive aging
por: Motsinger-Reif, Alison A, et al.
Publicado: (2013)

Comorbidity of age-related macular degeneration with Alzheimer’s disease: A histopathologic case-control study
por: Smilnak, Gordon J., et al.
Publicado: (2019)

Analysing connectivity with Granger causality and dynamic causal modelling
por: Friston, Karl, et al.
Publicado: (2013)

Blueberry Supplementation Effects on Neuronal and Pathological Biomarkers in Subjects at Risk for Alzheimer’s Disease: A Pilot Study
por: Doraiswamy, P.M., et al.
Publicado: (2023)

Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain
por: Rao, J S, et al.
Publicado: (2011)

Dynamic causal modelling revisited
por: Friston, K.J., et al.
Publicado: (2019)

Adiabatic dynamic causal modelling
por: Jafarian, Amirhossein, et al.
Publicado: (2021)

Comparing Families of Dynamic Causal Models
por: Penny, Will D., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_jr7hmeo4ipjel7md5qovkf0qk3